Long-term Anaemia Control in Dialysis Patients in Switzerland
Author Information
Author(s): Mathieu Claudine M, Teta Daniel, Lötscher Nathalie, Golshayan Dela, Gabutti Luca, Kiss Denes, Martin Pierre-Yves, Burnier Michel
Primary Institution: University Hospital CHUV, Department of Nephrology, Lausanne, Switzerland
Hypothesis
Can continuous long-term anaemia control be achieved in dialysis patients in Switzerland?
Conclusion
This study shows that Swiss dialysis centres achieved remarkable and continuous control of anaemia through careful management and EPO dosing.
Supporting Evidence
- 85% of patients achieved mean Hb ≥ 11 g/dL.
- Mean Hb was stable at 11.9 ± 1.0 g/dL over the year.
- One year survival was significantly higher in patients with Hb ≥ 11 g/dL.
Takeaway
Doctors in Switzerland helped kidney patients keep their blood levels healthy over a year by giving them medicine and checking them regularly.
Methodology
A prospective multi-centre observational study with monthly assessments over one year.
Potential Biases
Selection bias cannot be formally excluded as there was no random selection.
Limitations
The study includes a relatively small number of patients and did not account for several factors influencing Hb levels.
Participant Demographics
{"mean_age":63.9,"gender_distribution":{"female":41.4,"male":58.5},"dialysis_type":{"haemodialysis":94.9,"peritoneal_dialysis":5.1}}
Statistical Information
P-Value
0.006
Confidence Interval
95% CI: 127–146 IU/kg/week
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website